Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

Clinical Trial ID NCT01971281

Rank	Title	Journal	Year	PubWeight™‹?›
1	NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.	Eur J Cancer	2012	3.66
2	Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.	Proc Natl Acad Sci U S A	2007	2.64
3	Disruption of cancer cell replication by alternating electric fields.	Cancer Res	2004	2.62
4	Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs.	Clin Exp Metastasis	2009	1.15
5	Tumor treating fields: concept, evidence and future.	Expert Opin Investig Drugs	2011	0.99
6	A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer.	Lung Cancer	2013	0.98
7	An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.	Curr Treat Options Oncol	2015	0.83
8	Tumor treating fields: a novel treatment modality and its use in brain tumors.	Neuro Oncol	2016	0.78
9	2016 Gastrointestinal Cancers Symposium: update on pancreatic cancer.	Ann Gastroenterol	2016	0.75